These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19695461)

  • 1. Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression.
    Tereshchenko LG; Faddis MN; Fetics BJ; Zelik KE; Efimov IR; Berger RD
    J Am Coll Cardiol; 2009 Aug; 54(9):822-8. PubMed ID: 19695461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram.
    Stempniewicz P; Cheng A; Connolly A; Wang XY; Calkins H; Tomaselli GF; Berger RD; Tereshchenko LG
    J Cardiovasc Electrophysiol; 2011 May; 22(5):554-60. PubMed ID: 21087331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VV' Alternans Triplets on Near-Field ICD Intracardiac Electrogram is Associated with Mortality.
    Baumert M; Kabir MM; Dalouk K; Henrikson CA; Tereshchenko LG
    Pacing Clin Electrophysiol; 2015 May; 38(5):547-57. PubMed ID: 25752990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Subcutaneous Implantable Cardioverter-Defibrillator Shocks and Prognostic Impact in Patients With Structural Heart Disease.
    Ninni S; Echivard M; Marquié C; Ortmans S; Labreuche J; Drumez E; Lemaire J; Cuvillier A; Arnaud M; Potelle C; Gouraud JB; Andorin A; Blangy H; Sadoul N; Probst V; Klug D
    Can J Cardiol; 2021 Mar; 37(3):400-406. PubMed ID: 32474109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracardiac QT integral on far-field ICD electrogram predicts sustained ventricular tachyarrhythmias in ICD patients.
    Tereshchenko LG; Ghanem RN; Abeyratne A; Swerdlow CD
    Heart Rhythm; 2011 Dec; 8(12):1889-94. PubMed ID: 21802390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of implantable cardioverter defibrillator shocks during the first year.
    Dougherty CM; Hunziker J
    J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of defibrillator shocks in patients with heart failure.
    Poole JE; Johnson GW; Hellkamp AS; Anderson J; Callans DJ; Raitt MH; Reddy RK; Marchlinski FE; Yee R; Guarnieri T; Talajic M; Wilber DJ; Fishbein DP; Packer DL; Mark DB; Lee KL; Bardy GH
    N Engl J Med; 2008 Sep; 359(10):1009-17. PubMed ID: 18768944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation.
    Mitchell LB; Pineda EA; Titus JL; Bartosch PM; Benditt DG
    J Am Coll Cardiol; 2002 Apr; 39(8):1323-8. PubMed ID: 11955850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients.
    Bae MH; Cho Y; Hwang J; Park HS; Han S; Lee YS; Cho HJ; Jung BC; Lee CH; Hyun DW; Park JS; Ahn J; Kim KH; Shin DG
    J Korean Med Sci; 2020 Mar; 35(9):e49. PubMed ID: 32141247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death.
    Pappone C; Vicedomini G; Augello G; Mazzone P; Nardi S; Rosanio S
    Am J Cardiol; 2003 May; 91(9A):74F-80F. PubMed ID: 12729853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
    Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.